CSK |
CSK: Tyrosine-protein kinase CSK |
STAT1 |
STAT1: Signal transducer and activator of transcription 1-alpha/beta |
104.000 |
Evidence |
|
RET |
RET: Proto-oncogene tyrosine-protein kinase receptor ret precursor |
GRB2 |
GRB2, ASH: Growth factor receptor-bound protein 2 |
104.000 |
Evidence |
|
RASA1 |
RASA1, RASA: Ras GTPase-activating protein 1 |
ERBB3 |
ERBB3, HER3: Receptor tyrosine-protein kinase erbB-3 precursor |
104.000 |
Evidence |
|
ITK |
ITK, EMT, LYK: Tyrosine-protein kinase ITK/TSK |
CBLB |
CBLB, RNF56, Nbla00127: E3 ubiquitin-protein ligase CBL-B |
104.000 |
Evidence |
|
VAV1 |
VAV1, VAV: Proto-oncogene vav |
ERBB3 |
ERBB3, HER3: Receptor tyrosine-protein kinase erbB-3 precursor |
104.000 |
Evidence |
|
ERBB3 |
ERBB3, HER3: Receptor tyrosine-protein kinase erbB-3 precursor |
STAT5A |
STAT5A, STAT5: Signal transducer and activator of transcription 5A |
104.000 |
Evidence |
|
CBLB |
CBLB, RNF56, Nbla00127: E3 ubiquitin-protein ligase CBL-B |
PTK2B |
PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta |
104.000 |
Evidence |
|
NCK1 |
NCK1, NCK: Cytoplasmic protein NCK1 |
ERBB3 |
ERBB3, HER3: Receptor tyrosine-protein kinase erbB-3 precursor |
104.000 |
Evidence |
|
ENO2 |
ENO2: Gamma-enolase |
PRKCE |
PRKCE, PKCE: Protein kinase C epsilon type |
104.000 |
Evidence |
|
GNAI1 |
GNAI1: Guanine nucleotide-binding protein G(i), alpha-1 subunit |
GNAI2 |
Galphai2 protein |
104.000 |
Evidence |
|
TEC |
TEC, PSCTK4: Tyrosine-protein kinase Tec |
SYK |
SYK: Tyrosine-protein kinase SYK |
104.000 |
Evidence |
|
STAT2 |
STAT2: Signal transducer and activator of transcription 2 |
JAK1 |
|
102.000 |
Evidence |
|
ABL1 |
ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 |
IGF1R |
IGF1R: Insulin-like growth factor 1 receptor precursor |
102.000 |
Evidence |
|
CASP2 |
CASP2, ICH1, NEDD2: Caspase-2 precursor |
FADD |
FADD, MORT1: Protein FADD |
102.000 |
Evidence |
|
ZAP70 |
ZAP70: Uncharacterized protein ZAP70 |
PTK6 |
PTK6, BRK: Tyrosine-protein kinase 6 |
102.000 |
Evidence |
|
HLA-A |
HLA-A, HLAA: HLA class I histocompatibility antigen, A-3 alpha chain precursor |
CD1A |
CD1A: T-cell surface glycoprotein CD1a precursor |
102.000 |
Evidence |
|
ZAP70 |
ZAP70: Uncharacterized protein ZAP70 |
BLNK |
BLNK, BASH, SLP65: B-cell linker protein |
102.000 |
Evidence |
|
CD1A |
CD1A: T-cell surface glycoprotein CD1a precursor |
HLA-C |
HLA-C, HLAC: HLA class I histocompatibility antigen, Cw-7 alpha chain precursor |
102.000 |
Evidence |
|
ID2 |
ID2: DNA-binding protein inhibitor ID-2 |
ID3 |
ID3, 1R21, HEIR-1: DNA-binding protein inhibitor ID-3 |
102.000 |
Evidence |
|
CD1A |
CD1A: T-cell surface glycoprotein CD1a precursor |
HLA-G |
HLA-G, HLA-6.0, HLAG: HLA class I histocompatibility antigen, alpha chain G prec |
102.000 |
Evidence |
|
PRSS1 |
PRSS1, TRP1, TRY1, TRYP1: Trypsin-1 precursor |
SERPINF2 |
SERPINF2, AAP, PLI: Alpha-2-antiplasmin precursor |
102.000 |
Evidence |
O
|
HLA-B |
HLA-B, HLAB: HLA class I histocompatibility antigen, B-7 alpha chain precursor |
CD1A |
CD1A: T-cell surface glycoprotein CD1a precursor |
102.000 |
Evidence |
|
STX11 |
STX11: Syntaxin-11 |
STXBP2 |
STXBP2, UNC18B: Syntaxin-binding protein 2 |
102.000 |
Evidence |
|
STX3A |
STX3, STX3A: Syntaxin-3 |
STX1A |
STX1A, STX1: Syntaxin-1A |
102.000 |
Evidence |
|
GNA14 |
GNA14: Guanine nucleotide-binding protein alpha-14 subunit |
GRK5 |
GRK5, GPRK5: G protein-coupled receptor kinase 5 |
102.000 |
Evidence |
|